Snowden Capital Advisors LLC Novartis Ag Transaction History

Snowden Capital Advisors LLC

$3.02 Billion
Q1 2025

A detailed history of Snowden Capital Advisors LLC transactions in Novartis Ag stock. As of the latest transaction made, Snowden Capital Advisors LLC holds 11,446 shares of NVS stock, worth $1.32 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

11,446

Previous 13,099 12.62%

Holding current value

$1.32 Million

Previous $1.27 Million 0.16%

% of portfolio

0.04%

Previous 0.04%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	SELL	$97.14 - $115.57 $160,572 - $191,037	-1,653 Reduced 12.62%	11,446 $1.28 Million
Q4 2024 Feb 14, 2025	SELL	$96.78 - $117.18 $70,939 - $85,892	-733 Reduced 5.3%	13,099 $1.27 Million
Q3 2024 Nov 14, 2024	SELL	$106.13 - $120.89 $266,704 - $303,796	-2,513 Reduced 15.37%	13,832 $1.59 Million
Q2 2024 Aug 14, 2024	BUY	$92.57 - $107.37 $75,999 - $88,150	821 Added 5.29%	16,345 $1.74 Million
Q1 2024 May 15, 2024	BUY	$95.27 - $108.47 $44,014 - $50,113	462 Added 3.07%	15,524 $1.5 Million
Q4 2023 Feb 14, 2024	BUY	$92.27 - $101.54 $105,464 - $116,060	1,143 Added 8.21%	15,062 $1.52 Million
Q3 2023 Nov 14, 2023	SELL	$94.73 - $105.13 $129,969 - $144,238	-1,372 Reduced 8.97%	13,919 $1.42 Million
Q2 2023 Aug 14, 2023	SELL	$92.52 - $104.91 $98,996 - $112,253	-1,070 Reduced 6.54%	15,291 $1.54 Million
Q1 2023 May 15, 2023	SELL	$80.03 - $92.81 $40,975 - $47,518	-512 Reduced 3.03%	16,361 $1.51 Million
Q4 2022 Feb 13, 2023	SELL	$75.55 - $92.52 $54,773 - $67,077	-725 Reduced 4.12%	16,873 $1.53 Million
Q3 2022 Nov 09, 2022	SELL	$74.61 - $87.26 $322,240 - $376,875	-4,319 Reduced 19.71%	17,598 $1.34 Million
Q2 2022 Aug 12, 2022	SELL	$80.52 - $93.75 $141,071 - $164,250	-1,752 Reduced 7.4%	21,917 $1.85 Million
Q1 2022 May 16, 2022	BUY	$80.11 - $90.62 $1.63 Million - $1.84 Million	20,307 Added 604.02%	23,669 $2.08 Million
Q4 2021 Feb 14, 2022	BUY	$79.7 - $88.13 $267,951 - $296,293	3,362 New	3,362 $294,000
Q3 2021 Feb 05, 2024	BUY	$81.78 - $95.14 $1.11 Million - $1.29 Million	13,611 Added 97.79%	27,530 $2.25 Billion
Q2 2021 Jan 08, 2024	BUY	$85.24 - $94.15 $1.24 Million - $1.37 Million	14,598 Added 116.75%	27,102 $2.47 Billion
Q1 2021 Jan 08, 2024	BUY	$83.5 - $98.47 $551,684 - $650,591	6,607 Added 112.04%	12,504 $1.07 Billion
Q4 2020 Jan 08, 2024	BUY	$78.07 - $94.43 $224,373 - $271,391	2,874 Added 95.07%	5,897 $557 Million
Q3 2020 Jan 08, 2024	SELL	$82.14 - $91.0 $15,113 - $16,744	-184 Reduced 5.74%	3,023 $263 Million
Q2 2020 Jan 08, 2024	SELL	$80.93 - $91.1 $10,197 - $11,478	-126 Reduced 3.78%	3,207 $280 Million
Q1 2020 Jan 08, 2024	SELL	$70.67 - $99.01 $2,120 - $2,970	-30 Reduced 0.89%	3,333 $275 Million
Q4 2019 Jan 30, 2024	SELL	$84.35 - $95.37 $168 - $190	-2 Reduced 0.06%	3,363 $318 Million
Q4 2019 Jan 08, 2024	SELL	$84.35 - $95.37 $168 - $190	-2 Reduced 0.06%	3,363 $318 Million
Q3 2019 Jan 30, 2024	SELL	$85.54 - $94.26 $27,714 - $30,540	-324 Reduced 8.78%	3,365 $292 Million
Q3 2019 Jan 08, 2024	SELL	$85.54 - $94.26 $1.08 Million - $1.19 Million	-12,583 Reduced 78.9%	3,365 $292 Million
Q2 2019 Jan 30, 2024	SELL	$75.4 - $92.8 $771,342 - $949,344	-10,230 Reduced 73.5%	3,689 $337 Million
Q2 2019 Jan 08, 2024	BUY	$75.4 - $92.8 $923,574 - $1.14 Million	12,249 Added 331.14%	15,948 $338 Million
Q1 2019 Jan 08, 2024	BUY	$75.32 - $86.15 $16,871 - $19,297	224 Added 6.45%	3,699 $356 Million
Q4 2018 Jan 08, 2024	BUY	$73.66 - $82.02 $60,253 - $67,092	818 Added 30.79%	3,475 $298 Million
Q3 2018 Jan 08, 2024	SELL	$66.94 - $77.43 $753,878 - $872,016	-11,262 Reduced 80.91%	2,657 $229 Million

Others Institutions Holding NVS

# of Institutions

1,524

Shares Held

142M

Call Options Held

1.63M

Put Options Held

1.82M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $249B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Snowden Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Snowden Capital Advisors LLC with notifications on news.

Account

Snowden Capital Advisors LLC Novartis Ag Transaction History